Form 4 for NVAX NOVAVAX INC
Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-12 · accession 0001593968-25-000760 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-13 | 2025-06-12 | NVAX | King Rachel K. | Dir | M - OptEx | $0.00 | +10.4K | 25.2K | +71% | $0 |
| D | 2025-06-13 | 2025-06-12 | NVAX | King Rachel K. | Dir | M - OptEx | $0.00 | -10.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-12 | M | A | 10,420 | $0.00 | 25,190 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-06-12 | M | D | 10,420 | $0.00 | 0 | D | $0.00 · 2025-06-12 to 2034-06-12 | 10,420 Common Stock |